ATL results dip due to HDI 5000 intro

Article

HDI 5000 may represent the future for ATL Ultrasound, but expenses associated with the rollout of the new super-premium ultrasound scanner had a negative impact on the Bothell, WA, company's financial results for the third quarter (end-September). Still,

HDI 5000 may represent the future for ATL Ultrasound, but expenses associated with the rollout of the new super-premium ultrasound scanner had a negative impact on the Bothell, WA, company's financial results for the third quarter (end-September). Still, ATL executives say HDI 5000 is off to a roaring start, with deliveries scheduled for this quarter.

ATL had revenues of $93 million for the third quarter, down 7% compared with sales of $100.3 million in the third quarter of 1996. The firm's net loss for the most recent period was $2 million, compared with net income of $3.8 million in the same quarter a year ago.

ATL attributed the lower revenues to delays in customer order placement that followed HDI 5000's introduction in July, while expenses rose as the company readied the product for market (SCAN 8/6/97). Revenues and gross margin were also affected by the higher dollar, which negatively impacted the company's international business.

In other ATL news, the company announced last week that it has released a radiology version of its Tissue Harmonic Imaging technique, which previously had been available only for cardiology applications. The technique is available on the company's HDI 3000 scanner and will be offered on HDI 5000 when it begins shipping.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.